Longboard Pharmaceuticals...

NASDAQ: LBPH · Real-Time Price · USD
59.98
null (null%)
At close: Nov 29, 2024, 7:00 PM

Longboard Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a
Cost of Revenue
5K 5K 1K
Gross Profit
-5K -5K -1K
Operating Income
-56.76M -44.8M -27.84M
Interest Income
2.4M 837K 64K
Pretax Income
-54.42M -43.95M -27.8M
Net Income
-54.42M -43.09M -27.73M
Selling & General & Admin
13.01M 10.16M 8.06M
Research & Development
43.75M 34.64M 19.77M
Other Expenses
n/a 16K -22K
Operating Expenses
56.76M 44.8M 27.84M
Interest Expense
n/a 837K n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
56.76M 44.8M 27.84M
Income Tax Expense
n/a -853K -64K
Shares Outstanding (Basic)
22.73M 17.15M 17.07M
Shares Outstanding (Diluted)
22.73M 17.15M 17.07M
EPS (Basic)
-2.39 -2.51 -1.62
EPS (Diluted)
-2.39 -2.51 -1.62
EBITDA
-56.75M -44.79M -27.84M
EBIT
-56.76M -44.8M -27.84M
Depreciation & Amortization
5K 5K 1K